Understanding Class Actions and Your Rights as an Investor
In the ever-evolving landscape of investment, being informed about your rights is essential. Recently, several significant class actions have emerged that may impact your investments, particularly if you're a stockholder of DeFi Technologies Inc. (NASDAQ: DEFT), Skye Bioscience, Inc. (NASDAQ: SKYE), or Perrigo Company plc (NYSE: PRGO). Let's break down what you need to know about these cases.
DeFi Technologies Inc. Under Scrutiny
Recent Developments
DeFi Technologies Inc. (NASDAQ: DEFT) is at the center of a class action lawsuit with a class period spanning from May 12, 2025, to November 14, 2025. The lawsuit was spurred by allegations that the company made materially false and misleading statements regarding its business operations and future prospects.
Key Allegations Against DeFi
Allegations include claims that DeFi Technologies was experiencing delays in executing its DeFi arbitrage strategy, which is vital for generating revenue. Furthermore, the lawsuit contends that the entity understated competition from other companies, impacting its ability to implement its strategies effectively. Investors have until January 30, 2026, to appoint a lead plaintiff in this case.
Insights on Skye Bioscience, Inc.
Class Action Overview
Skye Bioscience, Inc. (NASDAQ: SKYE) has also come under fire in a class action that covers November 4, 2024, through October 3, 2025. The crux of the allegations revolves around misleading information pertaining to Skye's product nimacimab, especially regarding its efficacy and prospects.
Impact and Response
On October 6, 2025, Skye released results from a pivotal study of nimacimab that did not meet expectations, leading to a significant 60% drop in stock value in one day. Investors interested in this case should note the lead plaintiff’s deadline of January 16, 2026, for this class action.
Perrigo Company plc Under Investigation
What to Expect
Perrigo Company plc (NYSE: PRGO) is facing serious allegations in a class period from February 27, 2023, to November 4, 2025. This lawsuit outlines several critical failures including non-disclosure of significant issues within the company’s infant formula business.
Financial Discrepancies
As reported, Patterson's failure to convey financial hardships led to the company’s overstated earnings. When these issues came to light on November 5, 2025, Perrigo's stock plummeted by over 25%. Investors have until January 16, 2026, to act regarding this claim.
About Bragar Eagel & Squire, P.C.
Bragar Eagel & Squire, P.C. stands out as a distinguished law firm specializing in securing rights for investors. With offices throughout the U.S., including in New York, South Carolina, and California, they offer representation in a multitude of legal areas. Their extensive expertise spans securities, derivative, and commercial litigation, ensuring that investor rights are upheld nationwide.
Contact Information
If you're affected by any of these class actions or wish to understand your rights better, contact Bragar Eagel & Squire, P.C. You can reach out to Brandon Walker, Esq. or Melissa Fortunato, Esq. at (212) 355-4648, or via email at investigations@bespc.com. For more details about their services, visit www.bespc.com.
Frequently Asked Questions
What are the class action lawsuits about?
The lawsuits concern allegations of misleading statements by DeFi Technologies, Skye Bioscience, and Perrigo regarding their business operations and financial integrity.
How can I participate in a class action?
To participate, you typically need to file a motion to be appointed as a lead plaintiff before the deadline specified in the respective case.
What is the deadline for filing claims in these lawsuits?
Each case has a specific deadline; for DeFi and Skye, it's January 30 and January 16, 2026, respectively, while Perrigo's is also January 16, 2026.
Who can I contact for legal assistance?
You can contact Bragar Eagel & Squire, P.C. for assistance with these class actions or any other related legal inquiries.
What can be the outcome of these lawsuits?
Outcomes of class action lawsuits can potentially include settlements that may provide monetary relief to investors or changes in company practices.
